medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2004, Number 3

<< Back Next >>

An Med Asoc Med Hosp ABC 2004; 49 (3)

Dupuytren's disease

Fernández VJM, Camacho GJ, Luna A

Language: Spanish
References: 25
Page: 117-124
PDF size: 96.81 Kb.


ABSTRACT

Dupuytren’s contracture is a fibromatosis of fascia and palmar ligaments of the hand characterized by nodules and progressive contractures of the metacarpophalangeal and interphalangeal joints of the hand. In some cases it could affect soles of the feet or the penis. Most patients seek medical care when the disease has progressed with palpable cords and nodules, changes in the skin and progressive joint contractures. Usually it is a bilateral disease and one hand is more affected than the other. There is no relationship with the dominant hand. 70% of the patients have the pinky finger affected; in decreasing order of frequency are the ring, middle, thumb and index fingers. We present a retrospective serie of 57 patients, 48 male and 9 female surgically treated with Dupuytren’s disease, all of them had caucasian relatives, 11 had diabetes mellitus, 2 alcoholism and 2 epilepsy. The pinky and annular were the most frecuently affected fingers. Four patients had Peyronie´s disease and 6 Lederhose´s associated. Satisfactory results were obtained in 95% of the cases. Complication rate was 22% and recidivism was 5%.


REFERENCES

  1. Hindman HB, Marty-Roix R, Jupiter JB. Regulation of expression of a-smooth muscle actin in cells of Dupuytren’s contracture. J Bone Joint Surg (Br) 2003; 85-B: 448-455.

  2. Thurston AJ. Dupuytren’s disease. J Bone Joint Surg (Br) 2003; 85-B: 469-477.

  3. McFarlane RM. On the origin and spread of Dupuytren’s disease. J Hand Surg 2002; 27A: 385-390.

  4. Saar JD, Grothaus PC. Dupuytren’s disease: An overview. Plast Reconstr Surg 2000; 106: 125-134.

  5. Roush TF, Stern PJ. Results following surgery for recurrent Dupuytren’s disease. J Hand Surg 2000; 25A: 291-296.

  6. McFarlane RM. Dupuytren’s contracture. In: Green DP (ed). Green´s operative hand surgery. New York, NY: Churchill Livingstone, 1993: 563-591.

  7. Ulrich D, Hrynyschyn K, Pallua N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren’s disease. Plast Reconstr Surg 2003; 112: 1279-1286.

  8. Luck JV. Dupuytren’s contracture: A new concept of the pathogenesis with surgical management. J Bone Joint Surg (Am) 1959; 41: 635.

  9. McFarlane RM. Dupuytren’s disease: Relation to work and injury. J Hand Surg (Am) 1991; 16: 775-779.

  10. Moyer KE, Banducci DR, Graham WP. Dupuytren’s disease: Physiologic changes in nodule and cord fibroblasts through aging in vitro. Plast Reconstr Surg 2002; 110: 194-196.

  11. Badalamente MA, Sampson SP, Hurst LC. The role of transforming growth factor beta in Dupuytren’s disease. J Hand Surg 1996; 21A: 210-215.

  12. Alioto RJ, Rosier RN, Burton RI, Puzas JE. Comparative effects of grown factors on fibroblasts of Dupuytren”s tissue and normal palmar fascia. J Hand Surg (Am) 1994; 19: 442.

  13. Rayan GM, Parizi M, Tomasek JJ. Pharmacologic regulation of Dupuytren’s fibroblast contraction in vitro. J Hand Surg 1996; 21A: 1065-1070.

  14. Bilderback KK, Rayan GM. Dupuytren’s cord involving the septa of Legueu and Juvara: A case report. J Hand Surg 2002; 27A: 344-346.

  15. Umlas ME, Bischoff RJ, Gelberman RH. Predictors of neurovascular displacement in hands with Dupuytren’s disease. J Hand Surg (Br) 1994; 19: 664.

  16. Hueston JT. Dupuytren’s contracture and occupation. J Hand Surg (Am) 1987; 12: 657-658.

  17. Sanderson PL, Morris MA, Stanley JK, Fahmy NRM. Lipids and Dupuytren’s disease. J Bone Joint Surg (Br) 1992; 74-B: 923-927.

  18. Noble J, Heathcote J, Cohen H. Diabetes mellitus in the aetiology of Dupuytren’s disease. J Bone Joint Surg (Br) 1984; 66-B: 322-325.

  19. Arafa M, Noble J, Royle SG, Trail IA, Allen J. Dupuytren’s disease and epilepsy revisited. J Hand Surg (Br) 1992; 17-B: 221-224.

  20. Badalamente MA, Hurst LC. J Hand Surg 2000; 25A: 629-636.

  21. Pagnotta A, Specchia N, Soccetti A. Responsiveness of Dupuytren’s disease fibroblasts to 5 a-dihydrotestosterone. J Hand Surg 2003; 28A: 1029-1034.

  22. Badalamente MA, Hurst LC. Collagen as a clinical target: Nonoperative treatment of Dupuytren’s disease. J Hand Surg 2002; 27A: 788-798.

  23. Hurst LC, Badalamante MA. Non operative treatment of Dupuytren’s disease. Hand Clin 1999; 15: 97.

  24. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren’s disease with triamcinilone acetonide. J Hand Surg 2000; 25A: 1157-1162.

  25. Rowley DI, Couch M, Chesney RB, Norris SH. Assessment of percutaneous fasciotomy in the management of Dupuytren’s contracture. J Hand Surg (Br) 1984; 9: 163.




2020     |     www.medigraphic.com